![]() |
![]() |
||||||
Accession | Disease | Description | Year | Source | RNA-Seq | Count | Biomarkers |
GSE65391 | SLE | Longitudinal transcriptional pediatric SLE study with clinical parameters | 2015 | Blood | N | 996 |
![]() |
GSE45291 | Rheumatoid Arthritis | Inhibition of Lymphotoxin-LIGHT Signaling Reduces the Interferon Signature in Rheumatoid Arthritis Patients | 2013 | Blood | N | 805 |
![]() |
GSE74143 | Rheumatoid Arthritis | Whole blood gene expression from subjects with moderate to severe rheumatoid arthritis | 2015 | Blood | N | 377 |
![]() |
GSE57386 | Arthritis | Gene expression of biopsies, CD14+ and CD14- cells from RA, PsA and PsO patients with Infliximab treatment | 2014 | Tissue | N | 255 |
![]() |
GSE78068 | Rheumatoid Arthritis | Identification of baseline gene expression signatures predicting therapeutic responses to three biologic agents in rheumatoid arthritis: a retrospective observational study | 2016 | Blood | N | 209 |
![]() |
GSE66795 | Sjogren syndrome | A transcriptional signature of fatigue derived from patients with primary Sjögren's Syndrome | 2015 | Blood | N | 160 |
![]() |
GSE120178 | Rheumatoid Arthritis | Pharmacodynamic Biomarkers and Differential Effects of TNF- and GM-CSF-Targeting Biologics in Rheumatoid Arthritis | 2019 | Blood | Y | 147 |
![]() |
GSE54629 | Rheumatoid Arthritis | Whole-blood transcriptomic profiling highlights rituximab response in rheumatoid arthritis | 2015 | Blood | N | 138 |
![]() |
GSE117769 | Rheumatoid Arthritis | Psoriatic arthritis 10 ; Healthy 50 ; Rheumatoid arthritis 51 ; Ankylosing spondylitis 8 ; Rheumatoid or Psoriatic arthritis 1 | 2018 | Blood | Y | 120 |
![]() |
GSE10325 | SLE | Expression data from human peripheral blood subsets | 2008 | Blood | N | 67 |
![]() |
GSE66533 | Rhabdomyosarcoma | Expression Profiling of human Fusion-Positive and Fusion-Negative Rhabdomyosarcoma | 2015 | Tissue | N | 58 |
![]() |
GSE99967 | SLE | Identification of a neutrophil-related gene expression signature that distinguishes between adult patients with and without nephritis in active systemic lupus erythematosus | 2017 | Blood | N | 54 |
![]() |
GSE45867 | Rheumatoid Arthritis | Effects of tocilizumab versus methotrexate therapy on gene expression profiles in the early rheumatoid arthrtis synovium | 2013 | Tissue | N | 40 |
![]() |
GSE11886 | Ankulosing Spondilitis | Gene expression analysis of macrophages from ankylosing spondylitis patients reveals interferon-gamma dysregulation | 2008 | Blood | N | 33 |
![]() |
GSE25160 | Rheumatoid Arthritis | Combination of peripheral blood gene expression profiles and clinical parameters predicts response for tocilizumab (anti-IL6) treatment in rheumatoid arthritis | 2010 | Blood | N | 26 |
![]() |
GSE58173 | Myositis | Upregulation of immunoproteasome subunits in myositis indicates active inflammation with involvement of antigen presenting cells, CD8 T-cells and IFNγ | 2014 | Tissue | N | 18 |
![]() |